TO:
|
RNS
|
FROM:
|
CT Global Managed Portfolio Trust
PLC
|
DATE:
|
30 January 2025
|
LEI:
|
213800ZA6TW45NM9YY31
|
Unaudited Half-Year Results
The Board of CT Global Managed
Portfolio Trust PLC (the 'Company') announces the unaudited
half-year results of the Company for the six month period to 30
November 2024.
Income Shares - Financial Highlights and Performance Summary
for the Six Months
· Dividend
yield(1) of 6.5% at 30 November 2024, compared to the
yield on the FTSE All-Share Index of 3.6%. Dividends are paid
quarterly.
· Net asset
value total return(1) per Income share of +0.6% for the
six months, underperforming the total return of the FTSE All-Share
Index of +1.9% by -1.3 percentage points.
Growth Shares - Financial Highlights and Performance Summary
for the Six Months
· Net
asset value total return(1) per Growth share of +1.9%
for the six months, matching the total return of the FTSE All-Share
Index of +1.9%.
· Net asset value
total return per Growth share of +227.1% in the 15 years to 30
November 2024, the equivalent of +8.2%
compound(1) per year. This compares with the total return of the
FTSE All-Share Index of +191.4%, the equivalent of +7.4% compound
per year.
Notes:
(1) Yield, total
return and compound annual growth rate - See Alternative
Performance Measures.
Chairman's Statement
Highlights
· Net
asset value ('NAV') total
return for the six months of +0.6% for the Income shares and +1.9%
for the Growth shares as compared to the total return for the FTSE
All-Share Index of +1.9%
· Income share dividend yield of 6.5% at 30 November 2024
Investment Performance
For the six months to 30 November
2024, the NAV total return was +0.6% for the Income shares and
+1.9% for the Growth shares. The total return for the benchmark
index for both share classes, the FTSE All-Share Index, was +1.9%.
Of relevance and for interest, the FTSE All-Share Closed End
Investments Index total return was +2.9% for the period.
The US equity market performed
strongly over the period while UK equity market returns were much
more muted although they did finish the period on a more positive
note. The period immediately following the UK general election in
July saw the stock market perform strongly; however, the focus soon
moved to the Budget at the end of October. Fears of measures
thought likely to be included dampened investor sentiment. As a
result, the UK equity market gave up ground, though rallied in
November, perhaps as Budget uncertainty was replaced by certainty,
and perhaps as the US Presidential election result, or at least its
clear outcome, was viewed positively by investors.
For the first time since the
second half of 2021, the investment company sector was very
modestly ahead of mainstream UK equity indices with the average
sector discount broadly unchanged at an historically wide
15%.
The Growth Portfolio performed in
line with the benchmark. The principal contributors were investment
companies exposed to the strongly performing US stock market. The
leader with a gain of 21.5% was JPMorgan American Investment Trust
where the underlying assets more than matched the 15.3% rise of the
S&P Composite Index (sterling adjusted); however, because the
share price moved from a discount of 4% to a premium of over 1%
this led to the notable outperformance. Once again, specialist
technology trusts Allianz
Technology Trust and Polar
Capital Technology Trust delivered strong performances:
gaining 14.9% and 12.4% respectively. These investment companies
are very long-term holdings having been in the Growth Portfolio
since the Company's launch in April 2008 and have proved, many
times over, the value of being exposed to companies with exciting
secular growth prospects in the technology sector. The Growth
Portfolio's largest position is in private equity trust
HgCapital Trust, which
recorded a share price gain of 11.3%. The trust principally invests
in private companies in the European business software sector and
reported a 6.9% rise in NAV for the year to 30 September 2024. The
detractors in the Growth Portfolio were invested in one of two
areas. First was Europe where a combination of political
uncertainty, weak economic performance in Germany and the threat of
tariffs from the new administration in the US were behind
Baillie Gifford European Growth
Trust and European
Opportunities Trust falling by 13.9% and 10.6% respectively.
The second area was investment companies which are specialists in
UK medium and smaller companies. Here performance was weak in the
period preceding the UK Budget where fears that higher taxes could
undermine growth in the domestic economy took hold. Although net
asset performance was reasonable, discounts on these trusts
widened. This caused share prices to decline; for example
JPMorgan UK Small Cap Growth &
Income fell by 9.4% and Henderson Smaller Companies Investment
Trust was 5.8% lower. Discounts on these trusts had moved to
12% and 14% respectively at 30 November 2024, which are
historically wide levels.
The Income Portfolio lagged the
benchmark slightly with the main cause being a lack of exposure to
investment companies invested in the US stock market. This is due
to a lack of dividends from most trusts invested in the US. Where
dividends can be found, they were the best performers over the
period under review. A good example was International Biotechnology Trust
(almost wholly US invested) which achieved strong net asset
performance due to a number of its holdings being acquired by large
pharmaceutical companies. This led to a share price gain of 14.8%.
The trust pays a dividend bi-annually from capital reserves
equivalent to 4% of its year end NAV which makes it an ideal holding for the Income Portfolio.
JPMorgan Global Growth &
Income is similar in that it also pays a dividend equivalent
to 4% of its year end NAV on a quarterly basis. This has freed up
the managers such that they are able to hold companies,
particularly in the US technology sector, which do not pay
dividends. Over 70% of its assets are held in the US. This was
behind a strong share price gain of 12.3% and helped the trust to
continue its outperformance. Of the laggards were investment
companies in the 'alternatives' sector, especially in the
infrastructure and renewables sub-sector which had a difficult
period. Lower energy prices affected asset values in the short
term; however, the influence of higher bond yields on share prices
was the main cause of share price underperformance. Both
Greencoat UK Wind and
The Renewables Infrastructure
Group experienced a 7% decline in their share prices,
despite announcing above inflation dividend increases and having
yields of over 8%. The discounts on these trusts moved to 20% and
26% respectively at 30 November 2024. As mentioned in the Growth
Portfolio review above, trusts invested in Europe and UK smaller
companies also detracted. Examples were JPMorgan European Growth & Income
which fell 7.7% and Invesco
Perpetual UK Smaller Companies Investment Trust which was
down 5.5%.
(All share prices are total
return.)
Dividends
As I referenced in the 2024 Annual
Report and Financial Statements, in the absence of unforeseen
circumstances, it was (and remains) the Board's intention to pay
four quarterly interim dividends, each of at least 1.85p per Income
share so that the aggregate dividends for the financial year to 31
May 2025 will be at least 7.40p per Income share (2024: 7.40p per
Income share).
To date, a first and second
interim dividend in respect of the year to 31 May 2025 have been
announced and paid, each at a rate of
1.85p per Income share (1.80p per Income share in the corresponding
periods in the year to 31 May 2024).
The minimum intended total
dividend for the financial year of 7.40p per Income share
represents a yield on the Income share price at 30 November 2024 of
6.5% which was materially higher than the yield of 3.6% on the FTSE
All- Share Index at the same date.
Borrowing
The Company's existing bank
facilities total £10 million and these
expire on 10 February 2025. Work is well advanced
with the Company's banker to replace these with a new
flexibly structured facility for the same amount.
At 30 November 2024 the Income
Portfolio had total borrowings drawn down of £7 million (10.6% of
gross assets), unchanged over the period, the investment of which
helps to boost net income after allowing for the interest cost. The
Growth Portfolio had no borrowings, also unchanged.
Management of Share Price Premium and Discount to
NAV
In normal circumstances the Board
aims to limit the discount to NAV at which the Company's shares
might trade to not more than 5%. During the six months to 30
November 2024 the Income shares traded at an average premium to NAV
of 1.1% and the Growth shares traded at an average discount of
-2.7%. At 30 November 2024, the Income shares stood at a premium to
NAV of 1.1% and the Growth shares at a discount to NAV of
-3.5%.
The Company is active in issuing
shares to meet demand and equally in buying back when this is
appropriate. During the six months to 30 November 2024, 50,000
Income shares were bought back for treasury at an average discount
of -3.0% to NAV and then subsequently sold from treasury at an
average premium of 1.7% to NAV. In addition, 285,000 new Income
shares were issued from the Company's block listing facilities at
an average premium to NAV of 1.7%. 815,000 Growth shares were also
bought back to be held in treasury at an average discount to NAV of
-3.2%.
Share Conversion Facility
Shareholders have the opportunity
to convert their Income shares into Growth shares or their Growth
shares into Income shares annually subject to minimum and maximum
conversion thresholds which may be reduced or increased at the
discretion of the Board. On 31 October 2024 the conversion
proceeded for those Shareholders who had elected to do so. The net
result of those conversions was an increase of 197,267 Income
shares and a decrease of 86,447 Growth shares in issue. The ability
to convert without incurring capital gains tax should be an
attractive facility for Shareholders and the next conversion date
(subject to minimum and maximum thresholds) will be in October
2025. Details will be provided when the Company's 2025 Annual
Report and Financial Statements is published in the
summer.
Outlook
Whatever one may think of the
results of the UK and US elections, both were at least decisive.
Such 'certainty' is often good for stock markets. However, the
economic impacts of both elections are less obvious at this stage
and while short term interest rates have fallen a little - and less
than had been hoped by now - longer term rates have risen, a move
that tends to be bad for stock markets. The rate of inflation is
proving stubborn, and both the US and UK Governments' borrowing
requirements look challenging. None of these observations is new
news and so should be discounted already by stock markets. As ever,
markets respond in either direction to events or news that is not
discounted. With a new and seemingly quite unpredictable US
President having taken office, the potential for new news is even
higher than usual.
The Board and Manager believe the
portfolios comprise quality investment companies and are well
diversified. In particularly uncertain times, these characteristics
should encourage investors, whatever new news appears.
David Warnock
Chairman
29 January 2025
Unaudited Condensed Income Statement
Six months to 30 November
2024
|
|
|
|
|
|
|
|
|
Notes
|
Revenue
|
Capital
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
Gains on investments
|
|
-
|
369
|
369
|
Foreign exchange gains
|
|
-
|
1
|
1
|
Income
|
2
|
2,613
|
-
|
2,613
|
Investment management fee
|
3
|
(145)
|
(368)
|
(513)
|
Other expenses
|
|
(365)
|
-
|
(365)
|
Return on ordinary activities before
finance costs and tax
|
|
2,103
|
2
|
2,105
|
Finance costs
|
|
(56)
|
(84)
|
(140)
|
Return on ordinary activities before tax
|
|
2,047
|
(82)
|
1,965
|
Tax on ordinary
activities
|
|
-
|
-
|
-
|
Return attributable to shareholders
|
|
2,047
|
(82)
|
1,965
|
Return per Income share - basic and
diluted (pence)
|
4
|
3.94p
|
(3.33p)
|
0.61p
|
Return per Growth share - basic and
diluted (pence)
|
4
|
-
|
4.68p
|
4.68p
|
|
|
|
|
`
|
|
|
|
|
| |
The total column of this statement
is the Profit and Loss Account of the Company. The supplementary
revenue and capital columns are prepared under guidance published
by The Association of Investment Companies.
All revenue and capital items in
the Income Statement derive from continuing operations.
Return attributable to
shareholders represents the profit/(loss) for the period and also
total comprehensive income.
Unaudited Condensed Income
Statement
Six months to 30 November
2023
|
|
|
|
|
|
|
|
|
Notes
|
Revenue
|
Capital
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
Losses on investments
|
|
-
|
(3,880)
|
(3,880)
|
Foreign exchange gains
|
|
-
|
1
|
1
|
Income
|
2
|
2,655
|
-
|
2,655
|
Investment management fee
|
3
|
(138)
|
(346)
|
(484)
|
Other expenses
|
|
(336)
|
-
|
(336)
|
Return on ordinary activities before
finance costs and tax
|
|
2,181
|
(4,225)
|
(2,044)
|
Finance costs
|
|
(57)
|
(85)
|
(142)
|
Return on ordinary activities before tax
|
|
2,124
|
(4,310)
|
(2,186)
|
Tax on ordinary
activities
|
|
-
|
-
|
-
|
Return attributable to shareholders
|
|
2,124
|
(4,310)
|
(2,186)
|
Return per Income share - basic and
diluted (pence)
|
4
|
4.19p
|
(7.54p)
|
(3.35p)
|
Return per Growth share - basic and
diluted (pence)
|
4
|
-
|
(1.31p)
|
(1.31p)
|
|
|
|
|
|
|
|
|
|
| |
The total column of this statement
is the Profit and Loss Account of the Company. The supplementary
revenue and capital columns are prepared under guidance published
by The Association of Investment Companies.
All revenue and capital items in
the Income Statement derive from continuing operations.
Return attributable to
shareholders represents the profit/(loss) for the period and also
total comprehensive income.
Condensed Income Statement
(audited)
Year to 31 May
2024(1)
|
|
|
|
|
|
|
|
|
Notes
|
Revenue
|
Capital
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Gains on investments
|
|
-
|
11,175
|
11,175
|
Foreign exchange losses
|
|
-
|
(6)
|
(6)
|
Income
|
2
|
5,167
|
-
|
5,167
|
Investment management fee
|
3
|
(280)
|
(702)
|
(982)
|
Other expenses
|
|
(659)
|
-
|
(659)
|
Return on ordinary activities before
finance costs and tax
|
|
4,228
|
10,467
|
14,695
|
Finance costs
|
|
(114)
|
(171)
|
(285)
|
Return on ordinary activities before tax
|
|
4,114
|
10,296
|
14,410
|
Tax on ordinary
activities
|
|
-
|
-
|
-
|
Return attributable to shareholders
|
|
4,114
|
10,296
|
14,410
|
Return per Income share - basic and
diluted (pence)
|
4
|
8.06p
|
(0.28p)
|
7.78p
|
Return per Growth share - basic and
diluted (pence)
|
4
|
-
|
28.33p
|
28.33p
|
|
|
|
|
| |
(1)
These figures are audited
The total column of this statement
is the Profit and Loss Account of the Company. The supplementary
revenue and capital columns are prepared under guidance published
by The Association of Investment Companies.
All revenue and capital items in
the Income Statement derive from continuing activities.
Return attributable to
shareholders represents the profit/(loss) for the year and also
total comprehensive income.
Unaudited Condensed Balance Sheet
As at 30 November
2024
|
|
|
|
Notes
|
Income
Shares
|
Growth
Shares
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
Fixed assets
|
|
|
|
|
Investments at fair value
|
6
|
64,292
|
89,662
|
153,954
|
|
|
|
|
|
Current assets
|
|
|
|
|
Debtors
|
7
|
279
|
231
|
510
|
Cash at bank and on
deposit
|
|
1,744
|
1,963
|
3,707
|
|
|
|
|
|
|
|
2,023
|
2,194
|
4,217
|
|
|
|
|
|
Creditors
Amounts falling due within one
year
|
8
|
(7,191)
|
(270)
|
(7,461)
|
|
|
|
|
|
Net
current (liabilities)/assets
|
|
(5,168)
|
1,924
|
(3,244)
|
|
|
|
|
|
Creditors
Amounts falling due in more than one
year
|
8
|
-
|
-
|
-
|
|
|
|
|
|
Net
assets
|
|
59,124
|
91,586
|
150,710
|
|
|
|
|
|
Capital and reserves:
|
|
|
|
|
Called-up share capital
|
9
|
3,157
|
2,347
|
5,504
|
Share premium
|
|
3,520
|
428
|
3,948
|
Capital redemption
reserve
|
|
1,950
|
1,698
|
3,648
|
2022 special reserve
|
|
29,588
|
29,581
|
59,169
|
2008 special reserve
|
|
19,681
|
6,916
|
26,597
|
Capital reserves
|
|
(2,727)
|
50,616
|
47,889
|
Revenue reserve
|
|
3,955
|
-
|
3,955
|
|
|
|
|
|
Equity shareholders' funds
|
|
59,124
|
91,586
|
150,710
|
|
|
|
|
|
Net
asset value per share (pence)
|
10
|
113.25p
|
264.16p
|
|
Unaudited Condensed Balance Sheet
As at 30 November
2023
|
|
|
|
Notes
|
Income
Shares
|
Growth
Shares
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
Fixed assets
|
|
|
|
|
Investments at fair value
|
|
61,270
|
82,417
|
143,687
|
|
|
|
|
|
Current assets
|
|
|
|
|
Debtors
|
7
|
550
|
182
|
732
|
Cash at bank and on
deposit
|
|
1,327
|
2,117
|
3,444
|
|
|
|
|
|
|
|
1,877
|
2,299
|
4,176
|
|
|
|
|
|
Creditors
Amounts falling due within one
year
|
8
|
(2,195)
|
(266)
|
(2,461)
|
|
|
|
|
|
Net
current (liabilities)/assets
|
|
(318)
|
2,033
|
1,715
|
|
|
|
|
|
Creditors
Amounts falling due in more than one
year
|
8
|
(5,000)
|
-
|
(5,000)
|
|
|
|
|
|
Net
assets
|
|
55,952
|
84,450
|
140,402
|
|
|
|
|
|
Capital and reserves:
|
|
|
|
|
Called-up share capital
|
|
3,299
|
2,498
|
5,797
|
Share premium
|
|
2,751
|
428
|
3,179
|
Capital redemption
reserve
|
|
1,760
|
1,553
|
3,313
|
2022 special reserve
|
|
29,588
|
29,581
|
59,169
|
2008 special reserve
|
|
19,464
|
12,352
|
31,816
|
Capital reserves
|
|
(4,673)
|
38,038
|
33,365
|
Revenue reserve
|
|
3,763
|
-
|
3,763
|
|
|
|
|
|
Equity shareholders' funds
|
|
55,952
|
84,450
|
140,402
|
|
|
|
|
|
Net
asset value per share (pence)
|
10
|
109.07p
|
228.97p
|
|
Condensed Balance Sheet (audited)
As
at 31 May 2024(1)
|
Notes
|
Income
shares
|
Growth
shares
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Fixed assets
|
|
|
|
|
Investments at fair
value
|
|
65,994
|
91,861
|
157,855
|
Current assets
|
|
|
|
|
Debtors
|
7
|
293
|
208
|
501
|
Cash at bank and on
deposit
|
|
1,200
|
476
|
1,676
|
|
|
|
|
|
|
|
1,493
|
684
|
2,177
|
Creditors
|
|
|
|
|
Amounts falling due within one
year
|
8
|
(7,223)
|
(310)
|
(7,533)
|
|
|
|
|
|
Net current (liabilities)/assets
|
|
(5,730)
|
374
|
(5,356)
|
|
|
|
|
|
Creditors
|
|
|
|
|
Amounts falling due in more than
one year
|
8
|
-
|
-
|
-
|
|
|
|
|
|
Net assets
|
|
60,264
|
92,235
|
152,499
|
|
|
|
|
|
Capital and reserves
|
|
|
|
|
Called-up share capital
|
|
3,134
|
2,353
|
5,487
|
Share premium
|
|
3,223
|
428
|
3,651
|
Capital redemption
reserve
|
|
1,950
|
1,698
|
3,648
|
2022 special reserve
|
|
29,588
|
29,581
|
59,169
|
2008 special reserve
|
|
19,464
|
9,206
|
28,670
|
Capital reserves
|
|
(998)
|
48,969
|
47,971
|
Revenue reserve
|
|
3,903
|
-
|
3,903
|
|
|
|
|
|
Equity shareholders' funds
|
|
60,264
|
92,235
|
152,499
|
|
|
|
|
|
Net asset value per share (pence)
|
10
|
116.51p
|
259.29p
|
|
(1)
These figures are audited
Unaudited Condensed Statement of Cash Flows
Six months to 30 November 2024
|
Notes
|
Income
shares
|
Growth
shares
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Net cash outflow from operations
before dividends
and interest
|
11
|
(376)
|
(535)
|
(911)
|
Dividends received
|
|
1,678
|
818
|
2,496
|
Interest received
|
|
20
|
41
|
61
|
Interest paid
|
|
(132)
|
-
|
(132)
|
Net cash inflow from operating activities
|
|
1,190
|
324
|
1,514
|
Investing activities
|
|
|
|
|
Purchases of
investments
|
|
(1,056)
|
(1,226)
|
(2,282)
|
Sales of investments
|
|
1,868
|
4,685
|
6,553
|
Cash flows from investing activities
|
|
812
|
3,459
|
4,271
|
Cash flows before financing activities
|
|
2,002
|
3,783
|
5,785
|
Financing activities
|
|
|
|
|
Equity dividends paid
|
5
|
(1,995)
|
-
|
(1,995)
|
Proceeds from issuance of new
shares, net of share
issuance
expenses
|
|
314
|
-
|
314
|
Shares purchased to be held in
treasury
|
|
(58)
|
(2,073)
|
(2,131)
|
Sale of shares from
treasury
|
|
58
|
-
|
58
|
Share conversion
|
|
223
|
(223)
|
-
|
Cash flows from financing activities
|
|
(1,458)
|
(2,296)
|
(3,754)
|
Net movement in cash and cash
equivalents
|
|
544
|
1,487
|
2,031
|
Cash and cash equivalents at the
beginning of the period
|
|
1,200
|
476
|
1,676
|
Cash and cash equivalents at the end of the
period
|
|
1,744
|
1,963
|
3,707
|
Represented by:
Cash at bank
|
|
214
|
43
|
257
|
Short-term deposits
|
|
1,530
|
1,920
|
3,450
|
|
|
1,744
|
1,963
|
3,707
|
Unaudited Condensed Statement of Cash Flows
Six months to 30 November 2023
|
Notes
|
Income
shares
|
Growth
shares
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Net cash outflow from operations
before dividends
and interest
|
11
|
(351)
|
(485)
|
(836)
|
Dividends received
|
|
1,525
|
782
|
2,307
|
Interest received
|
|
31
|
93
|
124
|
Interest paid
|
|
(135)
|
-
|
(135)
|
Net cash inflow from operating activities
|
|
1,070
|
390
|
1,460
|
Investing activities
|
|
|
|
|
Purchases of
investments
|
|
(4,651)
|
(5,686)
|
(10,337)
|
Sales of investments
|
|
3,242
|
4,383
|
7,625
|
Cash flows from investing activities
|
|
(1,409)
|
(1,303)
|
(2,712)
|
Cash flows before financing activities
|
|
(339)
|
(913)
|
(1,252)
|
Financing activities
|
|
|
|
|
Equity dividends paid
Proceeds from issuance of new
shares, net of share
issuance
expenses
|
5
|
(2,013)
633
|
-
-
|
(2,013)
633
|
Shared purchased to be held in
treasury
|
|
-
|
(2,536)
|
(2,536)
|
Sale of shares from
treasury
|
|
-
|
-
|
-
|
Share conversion
|
|
44
|
(44)
|
-
|
Cash flows from financing activities
|
|
(1,336)
|
(2,580)
|
(3,916)
|
Net movement in cash and cash
equivalents
|
|
(1,675)
|
(3,493)
|
(5,168)
|
Cash and cash equivalents at the
beginning of the period
|
|
3,002
|
5,610
|
8,612
|
Cash and cash equivalents at the end of the
period
|
|
1,327
|
2,117
|
3,444
|
Represented by:
Cash at bank
|
|
177
|
37
|
214
|
Short-term deposits
|
|
1,150
|
2,080
|
3,230
|
|
|
1,327
|
2,117
|
3,444
|
Condensed Statement of Cash Flows (audited)
Year to 31 May 2024(1)
|
Notes
|
Income
shares
|
Growth
shares
|
Total
|
|
|
£'000
|
£'000
|
£'000
|
|
|
|
|
|
Net cash outflow from operations
before dividends
and interest
|
11
|
(615)
|
(943)
|
(1,558)
|
Dividends received
|
|
3,181
|
1,515
|
4,696
|
Interest received
|
|
57
|
133
|
190
|
Interest paid
|
|
(268)
|
-
|
(268)
|
Net cash inflow from operating activities
|
|
2,355
|
705
|
3,060
|
Investing activities
|
|
|
|
|
Purchases of
investments
|
|
(10,193)
|
(10,167)
|
(20,360)
|
Sales of investments
|
|
8,474
|
10,054
|
18,528
|
Cash flows from investing activities
|
|
(1,719)
|
(113)
|
(1,832)
|
Cash flows before financing activities
|
|
636
|
592
|
1,228
|
Financing activities
|
|
|
|
|
Equity dividends paid
|
5
|
(3,863)
|
-
|
(3,863)
|
Proceeds from issuance of new
shares
|
|
1,381
|
-
|
1,381
|
Shares purchased to be held in
treasury
|
|
-
|
(5,682)
|
(5,682)
|
Sale of shares from
treasury
|
|
-
|
-
|
-
|
Share conversion
|
|
44
|
(44)
|
-
|
Cash flows from financing activities
|
|
(2,438)
|
(5,726)
|
(8,164)
|
Net movement in cash and cash
equivalents
|
|
(1,802)
|
(5,134)
|
(6,936)
|
Cash and cash equivalents at the
beginning of the period
|
|
3,002
|
5,610
|
8,612
|
Cash and cash equivalents at the end of the
period
|
|
1,200
|
476
|
1,676
|
Represented by:
Cash at bank
|
|
510
|
36
|
546
|
Short-term deposits
|
|
690
|
440
|
1,130
|
|
|
1,200
|
476
|
1,676
|
|
|
|
|
|
| |
(1) These figures are
audited
Unaudited Condensed Statement of Changes in
Equity
Six months to 30 November 2024
Income shares
|
Share
capital
£000
|
Share
premium
£000
|
Capital
redemption reserve
£000
|
2022
special
reserve
£000
|
2008
special
reserve
£000
|
Capital
reserves
£000
|
Revenue
reserve
£000
|
Total shareholders'
funds
£000
|
As at 31 May 2024
|
3,134
|
3,223
|
1,950
|
29,588
|
19,464
|
(998)
|
3,903
|
60,264
|
Increase in share capital in issue,
net of issuance expenses
|
17
|
297
|
-
|
-
|
-
|
-
|
-
|
314
|
Shares purchased for
treasury
|
-
|
-
|
-
|
-
|
(58)
|
-
|
-
|
(58)
|
Sale of shares from
treasury
|
-
|
-
|
-
|
-
|
58
|
-
|
-
|
58
|
Share conversion
|
6
|
-
|
-
|
-
|
217
|
-
|
-
|
223
|
Transfer of net income from Growth
to Income Portfolio
|
-
|
-
|
-
|
-
|
-
|
-
|
627
|
627
|
Transfer of capital from Income to
Growth Portfolio
|
-
|
-
|
-
|
-
|
-
|
(627)
|
-
|
(627)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,995)
|
(1,995)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
(1,102)
|
1,420
|
318
|
As
at 30 November 2024
|
3,157
|
3,520
|
1,950
|
29,588
|
19,681
|
(2,727)
|
3,955
|
59,124
|
|
|
|
|
|
|
|
|
|
Growth shares
|
|
|
|
|
|
|
|
|
As at 31 May 2024
|
2,353
|
428
|
1,698
|
29,581
|
9,206
|
48,969
|
-
|
92,235
|
Increase in share capital in issue,
net of issuance expenses
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Shares purchased for
treasury
|
-
|
-
|
-
|
-
|
(2,073)
|
-
|
-
|
(2,073)
|
Share conversion
|
(6)
|
-
|
-
|
-
|
(217)
|
-
|
-
|
(223)
|
Transfer of net income from Growth
to Income Portfolio
|
-
|
-
|
-
|
-
|
-
|
-
|
(627)
|
(627)
|
Transfer of capital from Income to
Growth Portfolio
|
-
|
-
|
-
|
-
|
-
|
627
|
-
|
627
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
1,020
|
627
|
1,647
|
As
at 30 November 2024
|
2,347
|
428
|
1,698
|
29,581
|
6,916
|
50,616
|
-
|
91,586
|
Total
|
|
|
|
|
|
|
|
|
As at 31 May 2024
|
5,487
|
3,651
|
3,648
|
59,169
|
28,670
|
47,971
|
3,903
|
152,499
|
Increase in share capital in issue,
net of issuance expenses
|
17
|
297
|
-
|
-
|
-
|
-
|
-
|
314
|
Shares purchased for
treasury
|
-
|
-
|
-
|
-
|
(2,131)
|
-
|
-
|
(2,131)
|
Sale of shares from
treasury
|
-
|
-
|
-
|
-
|
58
|
-
|
-
|
58
|
Share conversion
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,995)
|
(1,995)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
(82)
|
2,047
|
1,965
|
Total Company as at 30 November 2024
|
5,504
|
3,948
|
3,648
|
59,169
|
26,597
|
47,889
|
3,955
|
150,710
|
Unaudited Condensed Statement of Changes in
Equity
Six months to 30 November 2023
Income shares
|
Share
capital
£000
|
Share
premium
£000
|
Capital
redemption reserve
£000
|
2022
special
reserve
£000
|
2008
special
reserve
£000
|
Capital
reserves
£000
|
Revenue
reserve
£000
|
Total shareholders'
funds
£000
|
As at 31 May 2023
|
3,247
|
1,917
|
1,760
|
29,588
|
19,422
|
(853)
|
3,652
|
58,733
|
Increase in share capital in issue,
net of issuance expenses
|
50
|
834
|
-
|
-
|
-
|
-
|
-
|
884
|
Share conversion
|
2
|
-
|
-
|
|
42
|
-
|
-
|
44
|
Transfer of net income from Growth
to Income Portfolio
|
-
|
-
|
-
|
-
|
-
|
-
|
734
|
734
|
Transfer of capital from Income to
Growth Portfolio
|
-
|
-
|
-
|
-
|
-
|
(734)
|
-
|
(734)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,013)
|
(2,013)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
(3,086)
|
1,390
|
(1,696)
|
As
at 30 November 2023
|
3,299
|
2,751
|
1,760
|
29,588
|
19,464
|
(4,673)
|
3,763
|
55,952
|
|
|
|
|
|
|
|
|
|
Growth shares
|
|
|
|
|
|
|
|
|
As at 31 May 2023
|
2,500
|
428
|
1,553
|
29,581
|
14,930
|
38,528
|
-
|
87,520
|
Increase in share capital in issue,
net of issuance expenses
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Shares purchased for
treasury
|
-
|
-
|
-
|
-
|
(2,536)
|
-
|
-
|
(2,536)
|
Share conversion
|
(2)
|
-
|
-
|
-
|
(42)
|
-
|
-
|
(44)
|
Transfer of net income from Growth
to Income Portfolio
|
-
|
-
|
-
|
-
|
-
|
-
|
(734)
|
(734)
|
Transfer of capital from Income to
Growth Portfolio
|
-
|
-
|
-
|
-
|
-
|
734
|
-
|
734
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
(1,224)
|
734
|
(490)
|
As
at 30 November 2023
|
2,498
|
428
|
1,553
|
29,581
|
12,352
|
38,038
|
-
|
84,450
|
Total
|
|
|
|
|
|
|
|
|
As at 31 May 2023
|
5,747
|
2,345
|
3,313
|
59,169
|
34,352
|
37,675
|
3,652
|
146,253
|
Increase in share capital in issue,
net of issuance expenses
|
50
|
834
|
-
|
-
|
-
|
-
|
-
|
884
|
Shares purchased for
treasury
|
-
|
-
|
-
|
-
|
(2,536)
|
-
|
-
|
(2,536)
|
Share conversion
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(2,013)
|
(2,013)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
(4,310)
|
2,124
|
(2,186)
|
Total Company as at 30 November 2023
|
5,797
|
3,179
|
3,313
|
59,169
|
31,816
|
33,365
|
3,763
|
140,402
|
Condensed Statement of Changes
in Equity (audited)
Year to 31 May 2024(1)
Income Shares
|
Share
capital
£000
|
Share
premium
£000
|
Capital redemption
reserve
£000
|
2022
special
reserve
£000
|
2008
special
reserve
£000
|
Capital
reserves
£000
|
Revenue
reserve
£000
|
Total shareholders'
funds
£000
|
As at 31 May 2023
|
3,247
|
1,917
|
1,760
|
29,588
|
19,422
|
(853)
|
3,652
|
58,733
|
Increase in share capital in issue,
net of share issuance expenses
|
75
|
1,306
|
-
|
-
|
-
|
-
|
-
|
1,381
|
Share conversion
|
2
|
-
|
-
|
-
|
42
|
-
|
-
|
44
|
Cancellation of deferred
shares
|
(190)
|
-
|
190
|
-
|
-
|
-
|
-
|
-
|
Transfer of net income from Growth
to Income Portfolio
|
-
|
-
|
-
|
-
|
-
|
-
|
1,261
|
1,261
|
Transfer of capital from Income to
Growth Portfolio
|
-
|
-
|
-
|
-
|
-
|
(1,261)
|
-
|
(1,261)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,863)
|
(3,863)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
1,116
|
2,853
|
3,969
|
As
at 31 May 2024
|
3,134
|
3,223
|
1,950
|
29,588
|
19,464
|
(998)
|
3,903
|
60,264
|
Growth Shares
|
|
|
|
|
|
|
|
|
As at 31 May 2023
|
2,500
|
428
|
1,553
|
29,581
|
14,930
|
38,528
|
-
|
87,520
|
Increase in share capital in issue,
net of share issuance expenses
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Share conversion
|
(2)
|
-
|
-
|
-
|
(42)
|
-
|
-
|
(44)
|
Cancellation of deferred
shares
|
(145)
|
-
|
145
|
-
|
-
|
-
|
-
|
-
|
Transfer of net income from Growth
to Income Portfolio
|
-
|
-
|
-
|
-
|
-
|
-
|
(1,261)
|
(1,261)
|
Transfer of capital from Income to
Growth Portfolio
|
-
|
-
|
-
|
-
|
-
|
1,261
|
-
|
1,261
|
Share purchased for
treasury
|
-
|
-
|
-
|
-
|
(5,682)
|
-
|
-
|
(5,682)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
9,180
|
1,261
|
10,441
|
As
at 31 May 2024
|
2,353
|
428
|
1,698
|
29,581
|
9,206
|
48,969
|
-
|
92,235
|
Total
|
|
|
|
|
|
|
|
|
As at 31 May 2023
|
5,747
|
2,345
|
3,313
|
59,169
|
34,352
|
37,675
|
3,652
|
146,253
|
Increase in share capital in issue,
net of share issuance expenses
|
75
|
1,306
|
-
|
-
|
-
|
-
|
-
|
1,381
|
Share conversion
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cancellation of deferred
shares
|
(335)
|
-
|
335
|
-
|
-
|
-
|
-
|
-
|
Shares purchased for
treasury
|
-
|
-
|
-
|
-
|
(5,682)
|
-
|
-
|
(5,682)
|
Dividends paid
|
-
|
-
|
-
|
-
|
-
|
-
|
(3,863)
|
(3,863)
|
Return attributable to
shareholders
|
-
|
-
|
-
|
-
|
-
|
10,296
|
4,114
|
14,410
|
Total Company as at 31 May 2024
|
5,487
|
3,651
|
3,648
|
59,169
|
28,670
|
47,971
|
3,903
|
152,499
|
(1) These figures
are audited
Notes
1. Accounting policies
These condensed financial
statements, which are unaudited, have been prepared on a going
concern basis in accordance with the Disclosure Guidance and
Transparency Rules of the Financial Conduct Authority, FRS 102, FRS
104 'Interim Financial Reporting' and the Statement of Recommended
Practice 'Financial Statements of Investment Trust Companies and
Venture Capital Trusts' issued by The Association of Investment
Companies.
The accounting policies applied
for the condensed financial statements are set out in the Company's
Annual Report and Financial Statements for the year ended 31 May
2024.
2. Income
|
Six months
to
30 November
2024
|
Six months
to
30 November
2023
|
Year to
31 May
2024
|
|
£'000
|
£'000
|
£'000
|
UK dividends
|
1,911
|
1,850
|
3,639
|
Overseas dividends
|
583
|
568
|
1,151
|
Property income
distributions
|
58
|
113
|
187
|
Deposit interest
|
61
|
124
|
190
|
Total income
|
2,613
|
2,655
|
5,167
|
3. Investment management fee
|
Six months
to
30 November
2024
|
Six months
to
30 November
2023
|
Year to
31 May
2024
|
|
£'000
|
£'000
|
£'000
|
Investment management
fee
|
513
|
484
|
982
|
|
513
|
484
|
982
|
The Company's Investment Manager
is Columbia Threadneedle Investment Business Limited (the
'Manager'). The Manager receives an investment management fee at
the rate of 0.65% per annum of the total assets of each Portfolio
payable quarterly in arrears, subject to being reduced to 0.325%
per annum on any assets which are invested in other investment
vehicles managed by the Manager.
The terms of the Investment
Management Agreement with the Manager are also summarised in the
Company's Annual Report and Financial Statements to 31 May 2024. A
secretarial and administrative fee is also paid to the
Manager.
4. Return per share
The return per share for the six
months to 30 November 2024 is as follows:
|
Income
shares
|
Growth
shares
|
|
Revenue
|
Capital
|
Total
|
Revenue
|
Capital
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Return attributable to
Portfolios
|
1,420
|
(1,102)
|
318
|
627
|
1,020
|
1,647
|
Transfer of net income from Growth
Portfolio to Income Portfolio
|
627
|
-
|
627
|
(627)
|
-
|
(627)
|
Transfer of capital from Income
Portfolio to Growth Portfolio
|
-
|
(627)
|
(627)
|
-
|
627
|
627
|
Return attributable to
shareholders
|
2,047
|
(1,729)
|
318
|
-
|
1,647
|
1,647
|
Return per share
|
3.94p
|
(3.33p)
|
0.61p
|
-
|
4.68p
|
4.68p
|
Weighted average number of shares
in issue during the period
|
51,894,373
|
35,204,822
|
The return per share for the six
months to 30 November 2023 is as follows:
|
Income
shares
|
Growth
shares
|
|
Revenue
|
Capital
|
Total
|
Revenue
|
Capital
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Return attributable to
Portfolios
|
1,390
|
(3,086)
|
(1,696)
|
734
|
(1,224)
|
(490)
|
Transfer of net income from Growth
Portfolio to Income Portfolio
|
734
|
-
|
734
|
(734)
|
-
|
(734)
|
Transfer of capital from Income
Portfolio to Growth Portfolio
|
-
|
(734)
|
(734)
|
-
|
734
|
734
|
Return attributable to
shareholders
|
2,124
|
(3,820)
|
(1,696)
|
-
|
(490)
|
(490)
|
Return per share
|
4.19p
|
(7.54p)
|
(3.35p)
|
-
|
(1.31p)
|
(1.31p)
|
Weighted average number of shares
in issue during the period
|
50,632,769
|
37,456,146
|
The return per share for the
comparative year to 31 May 2024 is as follows:
|
Income
shares
|
Growth
shares
|
|
Revenue
|
Capital
|
Total
|
Revenue
|
Capital
|
Total
|
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
£'000
|
Return attributable to
Portfolios
|
2,853
|
1,116
|
3,969
|
1,261
|
9,180
|
10,441
|
Transfer of net income from Growth
Portfolio to Income Portfolio
|
1,261
|
-
|
1,261
|
(1,261)
|
-
|
(1,261)
|
Transfer of capital from Income
Portfolio to Growth Portfolio
|
-
|
(1,261)
|
(1,261)
|
-
|
1,261
|
1,261
|
Return attributable to
shareholders
|
4,114
|
(145)
|
3,969
|
-
|
10,441
|
10,441
|
Return per share
|
8.06p
|
(0.28p)
|
7.78p
|
-
|
28.33p
|
28.33p
|
Weighted average number of shares
in issue during the year
|
51,034,226
|
36,851,904
|
5. Dividends
|
Payment
|
Six months
to
30 November
2024
|
Six months
to
30 November
2023
|
Year to
31 May
2024
|
Dividends on Income shares
|
Date
|
£'000
|
£'000
|
£'000
|
Amounts recognised as
distributions during the period:
|
|
|
|
|
In respect of the previous financial year:
|
|
|
|
|
- fourth interim of 2.00p
(prior period: 2.19p) per Income share
|
5-Jul-2024
|
1,036
|
1,105
|
1,105
|
In respect of the period under review:
|
|
|
|
|
- first interim of 1.85p (prior
period: 1.80p) per Income share
|
11-Oct-2024
|
959
|
908
|
908
|
- second interim (prior period:
1.80p per share)
|
-
|
-
|
-
|
924
|
- third interim (prior period:
1.80p per share)
|
-
|
-
|
-
|
926
|
|
|
1,995
|
2,013
|
3,863
|
A second interim
dividend in respect of the year to 31 May 2025 of 1.85p per Income
share was paid on 10 January 2025 to shareholders on the register
on 13 December 2024. This amount has not been accrued in the
results for the six months to 30 November 2024.
For the financial year
to 31 May 2024 interim dividends totalled 7.40p per Income
share.
The Growth shares do not
carry an entitlement to receive dividends.
6. Investments
|
Income
shares
Level
1(1)
£'000
|
Growth
shares
Level
1(1)
£'000
|
Total
£'000
|
Cost at 31 May 2024
Gains at 31 May 2024
|
55,196
10,798
|
58,529
33,332
|
113,725
44,130
|
Valuation at 31 May
2024
Movement in the period
Purchases at cost
Sales proceeds
Gains on investments sold in the
period
Losses/(gains) on investments held
at period end
|
65,994
1,057
(1,868)
333
(1,224)
|
91,861
1,226
(4,685)
872
388
|
157,855
2,283
(6,553)
1,205
(836)
|
Valuation of investments held at 30 November
2024
|
64,292
|
89,662
|
153,954
|
Cost at 30 November
2024
Gains at 30 November
2024
|
54,718
9,574
|
55,942
33,720
|
110,660
43,294
|
Valuation at 30 November 2024
|
64,292
|
89,662
|
153,954
|
(1) Fair value hierarchy.
Gains/(losses) on investments
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
Gains on investments sold in the
period
(Losses)/gains on investments held
at period end
|
333
(1,224)
|
872
388
|
1,205
(836)
|
Total (losses)/gains on investments
|
(891)
|
1,260
|
369
|
The Company's Investments as
disclosed in the Balance Sheet are valued at fair value. The fair
value as at the reporting date has been estimated using the
following fair value hierarchy:
·
Level 1 - quoted prices (unadjusted) in active
markets for identical assets;
·
Level 2 - investments whose value is evidenced by
comparison with other observable current market transactions in the
same instrument or based on a valuation technique whose variables
includes only data from observable markets; and
·
Level 3 - investments whose value is not based on
observable market data.
There were no investments held
which were valued in accordance with Levels 2 or 3.
7. Debtors
30
November 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
Accrued Income
|
267
|
216
|
483
|
Other debtors and
prepayments
|
12
|
15
|
27
|
|
279
|
231
|
510
|
30
November 2023
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
Accrued Income
|
209
|
161
|
370
|
Due from brokers
|
251
|
-
|
251
|
Other debtors and
prepayments
|
90
|
21
|
111
|
|
550
|
182
|
732
|
31
May 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
Accrued Income
|
259
|
168
|
427
|
Other debtors and
prepayments
|
34
|
40
|
74
|
|
293
|
208
|
501
|
8. Creditors
Amounts falling due within one year
30
November 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
£5 million fixed rate term loan
maturing 10 February 2025
|
5,000
|
-
|
5,000
|
Revolving credit
facility
|
2,000
|
-
|
2,000
|
Management fee accrued
|
104
|
147
|
251
|
Secretarial fee accrued
|
10
|
16
|
26
|
Other accruals
|
77
|
107
|
184
|
|
7,191
|
270
|
7,461
|
|
|
|
|
Amounts falling due in more than one year
30
November 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
-
|
-
|
-
|
-
|
Amounts falling due within one year
|
|
|
|
30
November 2023
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
Revolving credit
facility
|
2,000
|
-
|
2,000
|
Management fee accrued
|
101
|
137
|
238
|
Secretarial fee accrued
|
12
|
19
|
31
|
Other accruals
|
82
|
110
|
192
|
|
2,195
|
266
|
2,461
|
Amounts falling due in more than one year
30
November 2023
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
£5m fixed rate term loan maturing
10 February 2025
|
5,000
|
-
|
5,000
|
Amounts falling due within one year
31
May 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
£5 million fixed rate term loan
maturing 10 February 2025
|
5,000
|
-
|
5,000
|
Revolving credit
facility
|
2,000
|
-
|
2,000
|
Management fee accrued
|
108
|
148
|
256
|
Secretarial fee accrued
|
10
|
16
|
26
|
Other accruals
|
105
|
146
|
251
|
|
7,223
|
310
|
7,533
|
Amounts falling due in more than one year
31
May 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
-
|
-
|
-
|
-
|
At 30 November 2024 the Company had
a £5 million unsecured fixed rate term loan and a £5 million
unsecured revolving credit facility ('RCF') with The Royal Bank of Scotland
International Limited. These facilities were put in place effective
10 February 2022 and are available until 10 February 2025. The
interest rate on the term loan is fixed at 2.78% per annum, (30
November 2023: 2.78%; 31 May 2024: 2.78%) and the interest rate on
the amounts drawn down under the RCF are variable based on SONIA
plus a margin and a non-utilisation fee is payable on undrawn
amounts.
During the six months to 30
November 2024 there were no changes in the amount borrowed
and
therefore no change in liabilities
arising from financing activities.
9. Share capital
|
Listed
|
Held in
treasury
|
In issue
|
|
Number
|
£'000
|
Number
|
£'000
|
Number
|
£'000
|
Income shares
|
|
|
|
|
|
|
Balance at 1 June
2024(1)
|
51,723,251
|
3,134
|
-
|
-
|
51,723,251
|
3,134
|
Issued
|
285,000
|
17
|
-
|
-
|
285,000
|
17
|
Purchased for treasury
|
-
|
-
|
(50,000)
|
(3)
|
(50,000)
|
(3)
|
Resold from treasury
|
-
|
-
|
50,000
|
3
|
50,000
|
3
|
Share conversion:
|
|
|
|
|
|
|
- Income to
Growth
|
(185,555)
|
(11)
|
-
|
-
|
(185,555)
|
(11)
|
- Growth to
Income
|
382,822
|
17
|
-
|
-
|
382,822
|
17
|
- Change in nominal
value(1)
|
-
|
(749)
|
-
|
-
|
-
|
(749)
|
Balance at 30 November 2024(1)
|
52,205,518
|
2,408
|
-
|
-
|
52,205,518
|
2,408
|
|
Deferred shares
-
Income
|
|
|
|
Number
|
£'000
|
|
|
|
|
Deferred shares - Income
|
|
|
|
|
|
|
Balance at 1 June 2024
|
-
|
-
|
|
|
|
|
Issue of 51,772,696
shares(2)
|
51,772,696
|
749
|
|
|
|
|
Balance at 30 November 2024
|
51,772,696
|
749
|
|
|
|
|
Total called-up share capital
|
|
3,157
|
|
|
|
|
(1) As part of the conversion process which was carried out
during the period in accordance with the Company's Articles,
the nominal value of each Income share changed from £0.060600579 to
£0.046131176 per Income share.
(2) The nominal value of a Deferred share is £0.014469403 per
share.
During the period, the Company
issued 285,000 (30 November 2023: 800,000; 31 May 2024: 1,225,000)
Income shares from the block listing facilities receiving net
proceeds of £333,000 (before share issuance expenses) (30 November
2023: £884,000; 31 May 2024: £1,381,000). During the period, the
Company bought back 50,000 (30 November 2023: nil; 31 May 2024:
nil) Income shares through the market for treasury at a cost of
£58,000 and resold out treasury 50,000 (30 November 2023: nil; 31
May 2024: nil) Income shares receiving net proceeds of
£58,000.
During the period, valid
conversion notices were received to convert 185,555 Income shares
(which represented a value of £210,000). These were converted into
81,313 Growth shares in accordance with the Company's Articles and
by reference to the ratio of the relative underlying net asset
values of the Growth shares and Income shares on the conversion
date.
The Company's Articles allow for
Deferred shares to be allotted as part of the share conversion to
ensure that the conversion does not result in a reduction of the
aggregate par value of the Company's issued share capital. The
Deferred shares issued as part of the share conversion in the
period are set out above. The Deferred shares will be repurchased
by the Company from time to time as last authorised by shareholders
at the October 2024 AGM.
|
Listed
|
Held in
treasury
|
In issue
|
|
Number
|
£'000
|
Number
|
£'000
|
Number
|
£'000
|
Growth shares
|
|
|
|
|
|
|
Balance at 1 June
2024(1)
|
38,827,608
|
2,353
|
(3,255,000)
|
(197)
|
35,572,608
|
2,156
|
Issued
|
-
|
-
|
-
|
-
|
-
|
-
|
Purchased for treasury
|
-
|
-
|
(815,000)
|
(45)
|
(815,000)
|
(45)
|
Share conversion:
|
|
|
|
|
|
|
- Growth to
Income
|
(167,760)
|
(10)
|
-
|
-
|
(167,760)
|
(10)
|
- Income to
Growth
|
81,313
|
4
|
-
|
-
|
81,313
|
4
|
- Change in nominal
value(1)
|
-
|
(560)
|
-
|
54
|
-
|
(506)
|
Balance at
30 November 2024(1)
|
38,741,161
|
1,787
|
(4,070,000)
|
(188)
|
34,671,161
|
1,599
|
|
Deferred shares
-
|
|
|
|
Growth
|
|
|
|
|
|
|
Number
|
£'000
|
|
|
|
|
Deferred shares - Growth
|
|
|
|
|
|
|
Balance at 1 June 2024
|
-
|
-
|
|
|
|
|
Issue of 38,659,848
shares(2)
|
38,659,848
|
560
|
|
|
|
|
Balance at 30 November 2024
|
38,659,848
|
560
|
|
|
|
|
Total called-up share capital
|
|
2,347
|
|
|
|
|
(1) As part of the conversion process which was carried out
during the period in accordance with the Company's Articles, the
nominal value of each Growth share changed from £0.060600579 to
£0.046131176 per Growth share.
(2) The nominal value of a Deferred share is £0.014469403 per
share.
During the period the Company
bought back 815,000 (30 November 2023: 1,130,000; 31 May 2024:
2,440,000) Growth shares at a cost of £2,073,000 (30 November 2023:
£2,536,000; 31 May 2024: £5,682,000) to be held in
treasury.
During the period, valid
conversion notices were received to convert 167,760 Growth shares
(which represented a value of £433,000). These were converted into
382,822 Income shares in accordance with the Company's Articles and
by reference to the ratio of the relative underlying net asset
values of the Growth shares and Income shares on the conversion
date.
The Company's Articles allow for
Deferred shares to be allotted as part of the share conversion to
ensure that the conversion does not result in a reduction of the
aggregate par value of the Company's issued share capital. The
Deferred shares issued as part of the share conversion in the
period are set out above. The Deferred shares will be repurchased
by the Company from time to time as last authorised by shareholders
at the October 2024 AGM.
10. Net asset
value per share
|
30 November
2024
|
30 November
2023
|
31 May
2024
|
Income shares
|
|
|
|
Net asset value per share -
pence
|
113.25p
|
109.07p
|
116.51p
|
Net assets attributable at end
of
period - £'000
|
59,124
|
55,952
|
60,264
|
Shares in issue at end of period -
number
|
52,205,518
|
51,298,251
|
51,723,251
|
|
|
|
|
Growth shares
|
|
|
|
Net asset value per share -
pence
|
264.16p
|
228.97p
|
259.29p
|
Net assets attributable at end
of
period - £'000
|
91,586
|
84,450
|
92,235
|
Shares in issue at end of period -
number
|
34,671,161
|
36,882,608
|
35,572,608
|
11. Reconciliation of return on ordinary
activities before tax to net cash outflow from
operations
Six
months to 30 November 2024
|
Income
shares
£'000
|
Growth shares
£'000
|
Total
£'000
|
Return on ordinary activities
before tax
|
318
|
1,647
|
1,965
|
Adjust for returns from
non-operating activities:
|
|
|
|
Losses/(gains) on
investments
|
891
|
(1,260)
|
(369)
|
Foreign exchange gains
|
(1)
|
-
|
(1)
|
Return from operating
activities
|
1,208
|
387
|
1,595
|
Decrease in prepayments
|
14
|
25
|
39
|
Decrease in creditors
|
(32)
|
(40)
|
(72)
|
Dividend income
|
(1,686)
|
(866)
|
(2,552)
|
Interest income
|
(20)
|
(41)
|
(61)
|
Interest expense
|
140
|
-
|
140
|
Net cash outflow from operations before dividends and
interest
|
(376)
|
(535)
|
(911)
|
|
|
|
| |
Six
months to 30 November 2023
|
Income
shares
£'000
|
Growth shares
£'000
|
Total
£'000
|
Return on ordinary activities
before tax
|
(1,696)
|
(490)
|
(2,186)
|
Adjust for returns from
non-operating activities:
|
|
|
|
Losses on investments
|
2,878
|
1,002
|
3,880
|
Foreign exchange gains
|
(1)
|
-
|
(1)
|
Return from operating
activities
|
1,181
|
512
|
1,693
|
Decrease in prepayments
|
-
|
3
|
3
|
Decrease in creditors
|
(10)
|
(8)
|
(18)
|
Withholding tax
suffered
|
(1)
|
-
|
(1)
|
Dividend income
|
(1,632)
|
(899)
|
(2,531)
|
Interest income
|
(31)
|
(93)
|
(124)
|
Interest expense
|
142
|
-
|
142
|
Net cash outflow from operations before dividends and
interest
|
(351)
|
(485)
|
(836)
|
|
|
|
| |
Year to 31 May 2024
|
Income
shares
£'000
|
Growth
shares
£'000
|
Total
£'000
|
Return on ordinary activities
before tax
|
3,969
|
10,441
|
14,410
|
Adjust for returns from
non-operating activities:
|
|
|
|
Gains on investments
|
(1,543)
|
(9,632)
|
(11,175)
|
Foreign exchange losses
|
6
|
-
|
6
|
Return from operating
activities
|
2,432
|
809
|
3,241
|
Increase in prepayments
|
(15)
|
(16)
|
(31)
|
Increase in creditors
|
18
|
36
|
54
|
Withholding tax
suffered
|
60
|
-
|
60
|
Dividend income
|
(3,338)
|
(1,639)
|
(4,977)
|
Interest income
|
(57)
|
(133)
|
(190)
|
Interest expense
|
285
|
-
|
285
|
Net cash outflow from operations before dividends and
interest
|
(615)
|
(943)
|
(1,558)
|
|
|
|
| |
12. Earnings
Earnings for the six months to 30 November 2024
should not be taken as a guide to the results for the full year to
31 May 2025.
13. Tax
The effective revenue
tax rate for the period to 30 November 2024 was nil% (30 November
2023: nil%; 31 May 2024: nil%). This is lower than the standard
rate of corporation tax due to the level of non-taxable dividend
income.
14. Going concern
In assessing the going concern
basis of accounting, the Directors have had regard to the guidance
issued by the Financial Reporting Council and have undertaken a
rigorous review of the Company's ability to continue as a going
concern. The Board has, in particular, considered the outlook for
inflation and ongoing macroeconomic and geopolitical
concerns.
The Company's investment objective
and policy, which is subject to regular Board monitoring processes,
is designed to ensure that the Company is invested principally in
listed securities. The value of these investments exceeds the
Company's liabilities by a significant margin. The Company retains
title to all assets held by its Custodian and has an agreement
relating to its borrowing facilities with which it has complied
during the period. Cash is only held with banks approved and
regularly reviewed by the Manager.
As part of the going concern
review, the Directors noted that the £5 million fixed rate term
loan and the £5 million revolving credit facility are committed to
the Company until 10 February 2025 and loan covenants are reviewed
by the Board on a regular basis. Work is well advanced with the
Company's banker to replace these with a new flexibly structured
facility for the same amount. Alternatively, any outstanding
borrowing could be repaid through the use of cash and, if required,
from the proceeds of the sale of the Company's investments in the
relevant Portfolio.
The Company does not have a fixed
life. However, the Company's Articles of Association require the
Board to next put a resolution to shareholders at the 2028 Annual
General Meeting ('AGM')
(and five yearly thereafter) to continue the Company. The
continuation vote will be proposed as an ordinary resolution. The
last such resolution was put to shareholders and passed at the AGM
held on 28 September 2023.
The Directors believe, having
assessed the principal risks and other matters in light of the
controls and review processes and bearing in mind the nature of the
Company's business and assets and revenue and expenditure
projections, that the Company has adequate resources to continue in
operational existence for a period of at least twelve months from
the date of approval of the financial statements. Accordingly, the
financial statements have been drawn up on the basis that the
Company is a going concern.
15. Related party transactions
The Board of Directors is
considered a related party. Under the FCA UK Listing Rules, the
Manager is also defined as a related party. However, the existence
of an independent Board of Directors demonstrates that the Company
is free to pursue its own financial and operating policies, and
therefore, under the AIC SORP, the Manager is not considered to be
a related party for accounting purposes.
There have been no transactions
with related parties during the first six months of the current
financial year that have materially affected the financial position
or performance of the Company during the period and there have been
no changes in the related party transactions described in the last
Annual Report and Financial Statements that could do so.
Investment management fees to the
Manager are set out in note 3 and note 8 where accrued management
fees and accrued secretarial fees are disclosed.
16. Results
The Company's auditor,
BDO LLP, has not audited or reviewed the Half-Year Report and the
results for the six months to 30 November 2024 and 30 November 2023
pursuant to the Auditing Practices Board guidance on 'Review of
Interim Financial Information'. These are not full statutory
financial statements in terms of Section 434 of the Companies Act
2006 and are unaudited. Statutory financial statements for the year
ended 31 May 2024, which received an unqualified audit report and
did not contain a statement under Section 498 of the Companies Act
2006, have been lodged with the Registrar of Companies. The
abridged financial statements included for the year ended 31 May
2024 are an extract from those financial statements. No full
statutory financial statements in respect of any period after 31
May 2024 have been reported on by the Company's auditor or
delivered to the Registrar of Companies.
The Half-Year Report to
30 November 2024 is available on the website maintained on behalf
of the Company at ctglobalmanagedportfolio.co.uk
Statement of Principal Risks and
Uncertainties
As an investment company, investing
primarily in listed securities, most of the Company's principal
risks and uncertainties that could threaten the achievement of its
objective, strategy, future performance, liquidity and solvency are
market‑related.
These risks, and the way in which
they are managed, are described in more detail under the heading
'Principal Risks and Uncertainties and Viability Statement' within
the Strategic Report in the Company's Annual Report and Financial
Statements for the year ended 31 May 2024.
The principal risks identified in
the Annual Report and Financial Statements were:
• market risk - the Company's
assets consist mainly of listed closed-end investment companies and
its principal risks are therefore market-related and include market
risk (comprising currency risk, interest rate risk and other price
risk), liquidity risk and credit risk;
• investment performance risk;
and
• third party service delivery and
cyber risk.
The Board continues to review the
key risk summary for the Company which identifies the risks that
the Company is exposed to, the controls in place and the actions
being taken to mitigate them. The Board has also considered the
outlook for inflation and ongoing macroeconomic and geopolitical
concerns.
The Board considers that the
Company's principal risks and uncertainties have not changed
materially since 26 July 2024, the date that the Company's Annual
Report and Financial Statements was approved, and are not expected
to change materially for the remainder of the Company's financial
year. The Board has also considered these principal risks in
relation to going concern, as set out in Note 14.
Statement of Directors' Responsibilities in Respect of the
Half-Year Report
We confirm that to the best of our
knowledge:
· the
condensed set of financial statements has been prepared in
accordance with applicable UK Accounting Standards on a going
concern basis and give a true and fair view of the assets,
liabilities, financial position and return of the
Company;
· the
Chairman's Statement and the Statement of Principal Risks and
Uncertainties (together constituting the Interim Management Report)
include a fair review of the information required by Disclosure
Guidance and Transparency Rule ('DTR') 4.2.7R, being an indication
of important events that have occurred during the first six months
of the financial year and their impact on the financial
statements;
· the
Statement of Principal Risks and Uncertainties is a fair review of
the principal risks and uncertainties for the remainder of the
financial year; and
· the
Half-Year Report includes a fair review of the information required
by DTR 4.2.8R, being related party transactions that have taken
place in the first six months of the current financial year and
that have materially affected the financial position or performance
of the Company during the period, and any changes in the related
party transactions described in the last Annual Report and
Financial Statements that could do so.
On behalf of the Board
David Warnock
Director
29 January 2025
Alternative Performance Measures ('APMs')
The Company uses the following
APMs. These are not statutory accounting measures and are not
intended as a substitute for statutory measures.
Discount/premium - the share
price of an investment company is derived from buyers and sellers
trading their shares on the stock market. This price is not
identical to the net asset value ('NAV') per share of the
underlying assets less liabilities of the Company. If the share
price is lower than the NAV per share, the shares are trading at a
discount. This usually indicates that there are more sellers of
shares than buyers. Shares trading at a price above NAV per share
are deemed to be at a premium usually indicating there are more
buyers of shares than sellers.
|
30
November 2024
|
|
31 May
2024
|
|
Income
|
Growth
|
|
Income
|
Growth
|
shares
|
shares
|
|
shares
|
shares
|
Net asset value per
share
|
(a)
|
113.25p
|
264.16p
|
|
116.51p
|
259.29p
|
Share price
|
(b)
|
114.50p
|
255.00p
|
|
119.00
|
254.00p
|
+Premium/ -discount (c =
(b-a)/(a))
|
(c)
|
+1.1%
|
-3.5%
|
|
+2.1%
|
-2.0%
|
Total return - the return to
shareholders calculated on a per share basis taking into account
both any dividends paid in the period and the increase or decrease
in the share price or NAV in the period. The dividends are assumed
to have been re-invested in the form of shares or net assets,
respectively, on the date on which the shares were quoted
ex-dividend.
The effect of reinvesting these
dividends on the respective ex-dividend dates and the share price
total returns and NAV total returns are shown below.
|
Six
months to
30
November 2024
|
|
Year
to
31 May
2024
|
Total return - NAV
|
Income
shares
|
Growth
shares
|
|
Income
Shares
|
Growth
Shares
|
NAV per share at start of
financial period/year
|
116.51p
|
259.29p
|
|
116.41p
|
230.12p
|
NAV per share at end of financial
period/year
|
113.25p
|
264.16p
|
|
116.51p
|
259.29p
|
Change in the
period/year
|
-2.8%
|
1.9%
|
|
0.1%
|
12.7%
|
Impact of dividend
reinvestments(1)
|
3.4%
|
n/a
|
|
6.9%
|
n/a
|
NAV total return for the
period/year
|
0.6%
|
1.9%
|
|
7.0%
|
12.7%
|
(1)
During the six months to 30 November 2024
dividends totalling 3.85p went ex-dividend with respect to the
Income shares. During the year to 31 May 2024 the equivalent figure
was 7.59p.
|
Six
months to
30
November 2024
|
|
Year
to
31 May
2024
|
Total return - Share
price
|
Income
shares
|
Growth
shares
|
|
Income
Shares
|
Growth
Shares
|
Share price per share at start of
financial period/year
|
119.0p
|
254.0p
|
|
121.0p
|
225.0p
|
Share price per share at end of
financial period/year
|
114.5p
|
255.0p
|
|
119.0p
|
254.0p
|
Change in the
period/year
|
-3.8%
|
0.4%
|
|
-1.7%
|
12.9%
|
Impact of dividend
reinvestment(1)
|
3.3%
|
n/a
|
|
6.9%
|
n/a
|
Share price total return for the
period/year
|
-0.5%
|
0.4%
|
|
5.2%
|
12.9%
|
(1) During the six months to 30 November 2024 dividends totalling
3.85p went ex-dividend with respect to the Income shares.
During the year to 31 May 2024 the equivalent figure was
7.59p.
Yield - the total annual
dividend expressed as a percentage of the period-end share
price.
|
|
30
November 2024
|
31 May
2024
|
|
|
£'000
|
£'000
|
Annual dividend
|
(a)
|
7.40p(1)
|
7.40p
|
Income share price
|
(b)
|
114.5p
|
119.0p
|
Yield (c = a/b)
|
(c)
|
6.5%
|
6.2%
|
(1)
Based on dividends at the expected minimum annual
rate of 7.40 pence per Income share for the
financial year
to 31 May 2025.
Net gearing/net cash - this
is calculated by expressing the Company's borrowings less cash and
cash equivalents as a percentage of shareholders' funds. If the
amount calculated is positive this is described as net gearing. If
the amount calculated is negative, this is described as net
cash.
|
30
November 2024
|
31 May
2024
|
|
Income
Shares
£'000
|
Growth
Shares
£'000
|
Income
Shares
£'000
|
Growth
Shares
£'000
|
Borrowings
|
7,000
|
-
|
7,000
|
-
|
Less cash and cash
equivalents
|
(1,744)
|
(1,963)
|
(1,200)
|
(476)
|
|
5,256
|
(1,963)
|
5,800
|
(476)
|
Shareholders' funds
|
59,124
|
91,586
|
60,264
|
92,235
|
+Net gearing/-net cash
|
+8.9%
|
-2.1%
|
+9.6%
|
-0.5%
|
Compound annual growth rate - converts the total return over a period of more than one year
to a constant annual rate of return applied to the compounded value
at the start of each year.
|
|
30
November 2024
|
|
|
Growth
shares
|
Indexed NAV total return at 30
November 2009
|
|
100.0
|
Indexed NAV total return at 30
November 2024
|
|
327.1
|
Period (years)
|
|
15.0
|
Compound annual growth
rate
|
|
8.2%
|
For further information, please
contact:
Peter Hewitt, Columbia
Threadneedle Investment Business
Limited
0131 573 8360
Ian Ridge, Columbia Threadneedle
Investment Business Limited
0131 573 8316
Sarah Gibbons-Cook, Quill
PR
07702
412680